IN2014DN10135A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10135A
IN2014DN10135A IN10135DEN2014A IN2014DN10135A IN 2014DN10135 A IN2014DN10135 A IN 2014DN10135A IN 10135DEN2014 A IN10135DEN2014 A IN 10135DEN2014A IN 2014DN10135 A IN2014DN10135 A IN 2014DN10135A
Authority
IN
India
Prior art keywords
present
formulations
kits
preparation
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Richard Wolf Garraway
John Mayo
William Henry
Original Assignee
Sequessome Technology Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd
Publication of IN2014DN10135A publication Critical patent/IN2014DN10135A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN10135DEN2014 2012-05-14 2013-05-10 IN2014DN10135A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1208409.1A GB201208409D0 (en) 2012-05-14 2012-05-14 Vesicular formulations, kits and uses
PCT/EP2013/059741 WO2013171132A1 (en) 2012-05-14 2013-05-10 Vesicular formulations, kits and uses

Publications (1)

Publication Number Publication Date
IN2014DN10135A true IN2014DN10135A (es) 2015-08-21

Family

ID=46458763

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10135DEN2014 IN2014DN10135A (es) 2012-05-14 2013-05-10

Country Status (9)

Country Link
US (1) US20150132349A1 (es)
EP (1) EP2849722A1 (es)
JP (1) JP2015516454A (es)
CN (1) CN104619311A (es)
DE (1) DE112013002488T8 (es)
GB (1) GB201208409D0 (es)
HK (1) HK1209026A1 (es)
IN (1) IN2014DN10135A (es)
WO (1) WO2013171132A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012003834A2 (pt) 2009-08-21 2017-08-08 Targeted Delivery Tech Limited métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
PL3316856T3 (pl) * 2015-06-30 2021-10-25 Sequessome Technology Holdings Limited Zmieszane formulacje

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661673B1 (fr) * 1990-05-07 1992-08-21 Oreal Association de dihydroxyacetone et de monohydroxyindoles pour conferer a la peau une coloration similaire au bronzage naturel, dispositif a plusieurs compartiments et procede de mise en óoeuvre.
US6165500A (en) 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
JP3765579B2 (ja) 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
ES2169566T3 (es) * 1997-11-19 2002-07-01 Schering Ag Composicion con acido azelaico.
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
FR2823100B1 (fr) * 2001-04-10 2003-05-30 Oreal Procede de maquillage bicouche et kit de maquillage contenant des premiere et seconde compositions
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US20060198849A1 (en) * 2003-02-25 2006-09-07 Shing Paau Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CN105434354A (zh) * 2009-06-03 2016-03-30 斯昆申技术控股有限责任公司 用于治疗深部组织疼痛的制剂
BR112012003834A2 (pt) * 2009-08-21 2017-08-08 Targeted Delivery Tech Limited métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
US20110273379A1 (en) * 2010-05-05 2011-11-10 Google Inc. Directional pad on touchscreen

Also Published As

Publication number Publication date
CN104619311A (zh) 2015-05-13
GB201208409D0 (en) 2012-06-27
DE112013002488T5 (de) 2015-01-29
JP2015516454A (ja) 2015-06-11
EP2849722A1 (en) 2015-03-25
US20150132349A1 (en) 2015-05-14
HK1209026A1 (en) 2016-03-24
DE112013002488T8 (de) 2015-02-19
WO2013171132A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
PH12014502697A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
EA201590887A1 (ru) Композиция
MX360499B (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
MX368615B (es) Derivados bicíclicos como inhibidores de la autotaxina (atx) que son inhibidores de la producción de ácido lisofosfatídico (lpa) y el uso de los mismos.
MY173843A (en) Amidine substituted ?-lactam compounds, their preparation and use as antibacterial agents
MD20150091A2 (ro) Compuşi antivirali
MX2011008864A (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
ECSP14013327A (es) Compuestos con actividad nematicida
PH12015501609A1 (en) Phenicol antibacterials
JO3154B1 (ar) عوامل مضادة لـ trpv4
MX2014005510A (es) Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
AU2014324961A8 (en) Highly potent glucocorticoids
IN2015DN00085A (es)
IN2014DN10135A (es)
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX2015004312A (es) Formulacion de aroma y fragancia (i).
MX359955B (es) Formulación de aroma y fragancia (iii).
EA201492280A1 (ru) Стабильный состав пексиганана
MX2015004316A (es) Formulacion de aroma y fragancia (iv).
MX2015004313A (es) Formulacion de aroma y fragancia (ii).
IN2013CH05591A (es)